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SUMMARY
Schistosoma haematobium antigen recognition profiles of the
human isotypes IgA, IgE, IgG1 and IgG4 were compared by
image analysis of western blots. Adult worm antigens sepa-
rated by two-dimensional gel electrophoresis were probed with
pooled sera from Zimbabweans resident in a S. haematobium
endemic area, followed by the identification of individual anti-
genic parasite proteins using mass spectrometry. Overall,
IgG1 reacted with the largest number of antigens, followed by
IgE and IgA which detected the same number, while IgG4
detected the fewest antigens. IgE recognized all antigens
reactive with IgG4 as well as an additional four antigens, an
isoform of 28-kDa GST, phosphoglycerate kinase, actin 1 and
calreticulin. IgG1 additionally recognized fatty acid–binding
protein, triose-phosphate isomerase and heat shock protein
70, which were not recognized by IgA. Recognition patterns
varied between some isoforms, e.g. the two fructose 1-6-bis-
phosphate aldolase isoforms were differentially recognized by
IgA and IgG1. Although the majority of S. haematobium
adult worm antigens are recognized by all of the four isotypes,
there are clear restrictions in antibody recognition for some
antigens. This may partly explain differences observed in iso-
type dynamics at a population level. Differential recognition
patterns for some isoforms indicated in the study have poten-
tial importance for vaccine development.
Keywords isotype, proteomics, recognition patterns, schisto-
somiasis
INTRODUCTION
Schistosomiasis is a major human parasitic disease in
tropical and subtropical countries in Africa, the Middle
East and South America (1). Urinary schistosomiasis
caused by Schistosoma haematobium affects over 100 mil-
lion people, and a recent survey in sub-Saharan Africa
indicated that 70 million individuals had experienced hae-
maturia and 32 million dysuria associated with S. haemat-
obium infection (http://www.who.int/vaccine_research/
diseases/soa_parasitic/en/index5.html Accessed 16th Sep-
tember 2010). Furthermore, it was estimated that 18 mil-
lion people suffered schistosome-related bladder wall
pathology and 10 million suffered hydronephrosis.
Epidemiological studies in endemic human populations
have shown that schistosome prevalence and intensity lev-
els rise to peak in childhood (around ages 9–14) (2) and
decline thereafter, so that in any endemic population, chil-
dren carry the heaviest infection levels while adults carry
little or no infection. This pattern has been taken to reflect
the development of immune-meditated resistance to infec-
tion ⁄ re-infection (2,3) and suggests that protective immune
responses develop slowly as a result of cumulative expo-
sure to parasite antigens (4). Early serum transfer studies
in the mouse model (5–8) as well as human immuno-epi-
demiological studies have shown that schistosome-specific
antibody responses are associated with protection to infec-
tion and re-infection (9–13). Despite the demonstration
that antibody-mediated responses can protect against
schistosome infection in experimental models, current
human schistosome vaccine research based on antibody-
mediated protection has stalled with the failure of many of
the vaccine candidate antigens to enter Phase III clinical
trials (14). Limitations in our current understanding of the
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development of protective anti-schistosome responses
against specific antigenic proteins may be contributing
to the slow development of effective anti-schistosome
vaccines. Previous studies characterizing immune responses
to schistosome proteins have relied on recombinant pro-
teins expressed in bacterial systems (15–17). However,
there are restrictions associated with this approach; for
example, it cannot detect immunogenic epitopes arising
from post-translational modifications. Recent develop-
ments in two-dimensional gel electrophoresis and proteo-
mics have the potential to overcome some of these
restrictions because crude parasite antigen preparations
can be separated into individual protein spots that can
then be identified by mass spectrometry analysis and
matched to newly available genomic databases.
The nature of the anti-schistosome antibody response
to crude antigen preparations has been studied in terms
of the different antibody isotypes involved and their rela-
tionship to each other, to host age and to schistosome
infection level by ourselves and others (for example, see
(4,11,18–21). Relatively few individual target antigens
have been analysed in the context of selective antibody
isotype recognition (22). IgA, IgE, IgG1 and IgG4 are of
particular interest as they have been implicated in the
development of protective human antischistosome immu-
nity. Hagan et al. demonstrated a significant relationship
between antischistosome IgE and IgG4 responses in
S. haematobium infections. Furthermore, they reported a
decrease in IgG4 accompanied by an increase in IgE with
host age, which was associated with resistance to re-infec-
tion after treatment (10). We have previously reported
that children exposed to S. haematobium produced a pre-
dominantly IgA response against egg and adult worm
antigens which was gradually replaced by an IgG1
response in adulthood (4). These studies were based on
immune responses to crude antigens containing a hetero-
geneous mixture of proteins and thus did not provide
any information on the recognition patterns of individual
antigens. Therefore, the antigenic source of variation in
isotype-specific responses to S. haematobium is unknown.
Differences may arise from the recognition of the same
antigen by different antibody classes, from the recogni-
tion of different antigens or a combination of both.
Identifying the individual antigens recognized by the dif-
ferent antibody isotypes in crude adult worm antigens
would help resolve the cause(s) of some of these differ-
ences. In this study, we used proteomic approaches in
combination with two-dimensional western blotting to
determine which adult worm antigens are recognized by
specific antibody isotypes ⁄ subclasses from schistosome-
infected ⁄ exposed individuals. Thus, we identify the iso-
type-specific recognition patterns of individual parasite
proteins within the crude adult S. haematobium proteome
for the first time. We identified antigens recognized by
IgA, IgE, IgG1 and IgG4, focussing our attention on
WHO vaccine candidate antigens (23). Characterizing the
antigens recognized by each antibody class will both
improve our understanding of naturally acquired schisto-
some-specific immunity and inform vaccine development
where the aim may be to stimulate an isotype-specific
antibody response to a single recombinant antigen rather
than a heterogeneous mixture of peptides. In this study,
we determined the reactivity of sera from 7- to 18-year-
olds, the age group where infection levels are changing
from rising, peaking and declining in this population
(24,25) to capture the range of immune reactivities as the
dynamics of infection change. The analyses were con-
ducted on pretreatment sera to study natural immune
reactivities before enhancement of antibody reactivity
with antihelminthic treatment, which we have previously
demonstrated in a different subgroup from the same pop-
ulation (26).
MATERIALS AND METHODS
Study area
The study was conducted in two rural villages in the
Mashonaland East Province of Zimbabwe (3130¢E;
1745¢S) where S. haematobium is endemic. The study area
is described in detail elsewhere (26). The study received
ethical and institutional approval from the Medical
Research Council of Zimbabwe and the University of
Zimbabwe, respectively. Permission to conduct the work in
this province was obtained from the Provincial Medical
Director. The villages were selected because health surveys
conducted regularly by the Ministry of Health and Child
Welfare in the region showed little or no infection with
other helminths and a low S. mansoni prevalence (<5%).
The selected villages had not been included in the
National Schistosome Control Programme and therefore
had not received treatment for schistosomiasis or other
helminth infections. The main activity in these villages is
subsistence farming. Drinking water is collected from open
wells while bathing and washing are conducted in two
main rivers in the villages. Most families maintain a gar-
den located near the river where water is collected for
watering the crops, and the schools surveyed were all in
close proximity to rivers.
Study subjects
The study participants are described in detail elsewhere
(26). Briefly, only permanent inhabitants of the villages
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who had never been treated for any helminth infection
were eligible for inclusion in the study. Informed consent
was obtained from all participants prior to enrolment into
the study. Following explanation of the project aims and
procedures to the community, school children and their
teachers, an initial parasitology (stool and urine samples)
and serology (blood sample) survey was conducted
amongst all compliant participants. A questionnaire sur-
vey confirmed that on average, all participants frequented
water contact sites at least four times per week and that
frequency of water contacts at the various sites was not
significantly different within the age range included in this
study (data not shown).
Parasitology samples (at least two urine and two stool
samples collected on 3 consecutive days) and 20 mL of
venous blood were collected from each participant. Stool
samples were processed following the Kato-Katz procedure
(27) to detect S. mansoni eggs and other intestinal helm-
inths, while the urine filtration method (28) was used to
detect S. haematobium eggs in urine samples. After collec-
tion of the samples, all participants were offered treatment
with the recommended dose of praziquantel, 40 mg ⁄kg
body weight. To be included in the cohort, participants
had to meet all of the following criteria: (1) have provided
at least two urine and two stool samples on consecutive
days for the detection of helminth parasites; (2) have given
a blood sample for serological assays; (3) be negative for
intestinal helminths and S. mansoni. In practice, all people
meeting criteria 1 and 2 were egg negative for intestinal
helminths and S. mansoni, and so no participants were
excluded on this third criterion. A total of 215 people
(110 men and 105 women) aged from 5 to 18 years met all
criteria. Serum samples obtained from 20 mL of venous
blood from each participant were frozen and stored in
duplicate at )20C in the field and transferred to a –80 C
freezer in the laboratory. One complete set of the samples
was subsequently transported frozen from Zimbabwe to
the United Kingdom, stored at )80C and defrosted for
the first time for use in this study. A serum pool for use as
a positive control in the western blot assays was made
using equal volumes (50 lL) of sera from each of the 215
participants irrespective of their schistosome infection sta-
tus and frozen in aliquots that were defrosted only once
for the immunoassays.
Parasite antigens
Adult worm antigens were used in this study as previous
studies have shown that adult S. haematobium parasites
suffer immune attrition and are targeted by host antibod-
ies (29). Soluble S. haematobium adult worm antigens
(SWAP) were obtained freeze-dried, from the Theodor
Bilharz Institute in Egypt, and reconstituted as previously
described (26). These were used in the subsequent gel elec-
trophoresis and immunoassays.
Antibody enzyme-linked immunosorbent assays
Circulating levels of IgA, IgE, IgG1 and IgG4 directed
against the S. haematobium adult worm antigens were
detected by indirect enzyme-linked immunosorbent assays
(ELISA) as previously described (4) using 5 lg ⁄mL of anti-
gen to coat plates, sera diluted at 1 : 50 and the secondary
horseradish peroxidase–conjugated secondary antibodies
IgE (Sigma A9667, Sigma Aldrich, Gillingham, UK),
IgG1(The Binding Site, AP006) and IgG4 (Ap009), all at
1 : 1000 dilution, and IgA (P0216; Dako, Cambridgeshire,
UK) which was diluted at 1 : 2000. Negative control sera
from five European volunteers who have never travelled to
tropical countries and therefore presumed not previously
exposed to schistosomiasis were also included in the assays
to generate reactivity cut-off points.
Gel electrophoresis
The soluble adult worm antigen preparation was separated
into constituent proteins by two-dimensional gel electro-
phoresis on 13-cm gels as previously described (26) to gen-
erate a reference gel used for identifying proteins (200 lg
of SWAP used) and the second (100 lg of SWAP used)
for western blotting to determine which antigens were rec-
ognized by the sera following a previously established pro-
tocol (4).
Determining sera and secondary antibody dilutions for
western blotting
To minimize differences in sensitivity and specificity of the
different assays arising from technical differences, assays
were optimized by titration assays. A pool of sera from all
of the Zimbabwean participants was used as a positive
control, while a pool of sera from five European volun-
teers (same as the ones used in the ELISA assays above)
was used as a negative control. The dilutions used for the
sera and secondary antibodies (IgA, IgE, IgG1 and IgG4)
were determined by a combination of enzyme-linked
immunosorbent assay (ELISA) titration assays and trial
western blots. First, ELISAs were conducted (varying both
secondary antibody (1 : 500–1 : 2000) and sera dilutions
(1 : 10–1 : 11280; see example in Figure S1) with 5 lg ⁄mL
of adult worm antigen. This informed the subsequent trial
western blots conducted using sera diluted at 1 : 200 or
1 : 400 to allow enough sample for all replicate assays and
to test a range of potential secondary antibody dilutions
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(1 : 1000, 1 : 2000, 1 : 4000) on a blot of 100 lg of two-
dimensional electrophoresis-separated SWAP. From these
data, we determined dilutions that gave the most consis-
tent replicates and optimal sensitivity and specificity for
each antibody isotype. Higher dilutions of secondary anti-
bodies resulted in the detection of fewer antigenic spots
(see Figure S2), while reducing the secondary antibody
dilution factor from 1 : 1000 (IgE, IgG1, IgG4) or
1 : 2000 (IgA) resulted in higher background rather than
an increase in the number of spots detected. Furthermore,
sera and secondary antibody dilutions used were consis-
tent with those we have previously used in ELISA (24,30)
and western blot assays (16), enabling our results to be
related to previous studies. The finalized protocol is
described elsewhere.
Western blotting
Western blotting was used to determine the proteins reac-
tive with the isotypes IgE, IgG4, IgA and IgG1 in sera
from the participants. To achieve this, proteins were trans-
ferred from the gel onto nitrocellulose membrane as previ-
ously described (26). Blots were run in pairs (one
gel ⁄membrane) to probe for two antibody isotypes at a
time in parallel assays. To verify efficient transfer of
SWAP proteins, membranes were stained with Ponceau S
solution (Sigma) and then blocked for 1 h at room tem-
perature in TBS blocking buffer [Pierce, (Thermo Scienti-
fic), Surrey, UK] with 0.05% Tween 20. This was followed
by 2 · 10 min washes with TBS ⁄ 0.05% Tween 20 ⁄ 0.5%
Triton-X 100 (TBS ⁄TT) (used for all washes). The pool of
positive control sera (diluted at 1 : 200 in TBS blocking
buffer with 0.02% Tween 20) was added to each of the
membranes and incubated overnight at 4C followed by
3 · 10 min washes. Horseradish peroxidise–conjugated sec-
ondary antibodies diluted in TBS blocking buffer ⁄ 0.05%
Tween 20 were then added to respective membranes
diluted at 1 : 1000 for IgE and 1 : 2000 for IgA. Mem-
branes were subsequently incubated at room temperature
for 1 h, followed by 4 · 10 min washes in TBS ⁄TT and
1 · 10 min washes in TBS alone. The proteins were visual-
ized using the chemiluminescence product ECL Plus (GE
Healthcare, Buckinghamshire, UK) according to the man-
ufacturer’s instructions. Films exposed to the blots for 5 s
were developed and spots matched to the Coomassie blue–
stained reference gel using the image analysis software
Image master. Following visualization, the membranes
were stripped of the ECL reagent, secondary antibody and
sera following the manufacturer’s protocol. The same
membranes were then re-probed using the same pool of
sera. The IgE membrane was re-probed with IgG4 diluted
at 1 : 1000, while the IgA membrane was re-probed with
IgG1 diluted at 1 : 1000. A previous assay showed that
the stripping procedure removed all proteins not directly
bound to the nitrocellulose membrane as indicated by the
lack of ECL reactivity with a stripped membrane. This
procedure did not remove any of the parasite proteins as
evidenced by probing the same membrane with three
serum samples successively, i.e. sera from the endemic
population, followed by negative control sera (a pool from
five Europeans who had never travelled to tropical
regions) and then by the same sera from the endemic pop-
ulation. An example of a membrane blotted with negative
control sera and the IgG4-specific secondary antibody is
shown in Figure S3. Gel electrophoresis and western blot-
ting were repeated twice using the secondary antibodies in
different order on the same membrane, i.e. IgG1 followed
by IgA and IgG4 followed by IgE to confirm the recogni-
tion patterns obtained.
Image analysis and mass spectrometry
Images from the western blots were electronically scanned
for image analysis. Spots on these blots were detected by
pixel analysis and matched across the different blots for
each isotype using the 2-D gel image analysis software
ImageMaster from GE Healthcare. All electronic spot
identifications and predicted matches were manually veri-
fied via independent visualization by two researchers.
Spots on the Coomassie blue–stained gel, which matched
to those on the western blots, were excised, digested with
trypsin and analysed by mass spectrometry analysis as
previously described (26). Data thus obtained were submit-
ted to an MSMS ion search via the Mascot search engine
(Matrix Science), searching both locally established data-
bases for S. mansoni EST sequence and the current nonre-
dundant NCBI database.
Data analysis
The ratios of IgG1 ⁄ IgA and IgE ⁄ IgG4 were calculated for
each individual from ELISA data for each individual. Par-
tial correlations were conducted to determine the associa-
tion between the ratios and schistosome infection intensity
allowing for residential village, age and sex. Significance
level for the statistics tests was set at P < 0.05. For all
analyses of antigenic spots, if the recognition intensity of
the spot after subtraction of the background intensity was
0 pixels, then the spot was designated ‘not recognized’ by
the isotype, and if it was greater than 0, then the antigenic
spot was designated as ‘recognized’. To allow comparisons
of the intensity of antigen recognition by the different iso-
types, the detected spots were categorized by their recogni-
tion intensity into five groups; group 1 comprised all
F. Mutapi et al. Parasite Immunology
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antigens not recognized by the pooled sera and groups
2–5 were based on the interquartile ranges for each isotype
using the mean intensity from the three replicate blots per
isotype. The interquartile ranges were calculated from the
antigens using a spot detected from pixel analysis and
manual verification. These ranges were calculated for each
isotype separately so that the spot intensities were
standardized within the gel. The intensity categories rather
than absolute values could then be compared across
the different gels. This approach was used as it does not
require any spots to be recognized equally by the four
isotypes for calibrating recognition intensity across all
isotypes.
RESULTS
Levels of IgA, IgE, IgG1 and IgG4 detected in individuals
The prevalence of S. haematobium infection in the partic-
ipants was 57%, and the corresponding mean infection
intensity was 36 eggs ⁄ 10 mL urine (SE of the mean =
5.7), with individual egg counts ranging from 0 to 676
eggs ⁄ 10 mL urine. Individual infection intensity followed
the typical age infection profile for schistosome infec-
tions, rising with age to peak in childhood and then
declining thereafter as shown in Figure 1a. The levels of
the four antibody isotypes IgA, IgE, IgG1 and IgG4
directed against adult worm antigen were measured for
each individual who was included in the serum pool. A
participant was considered reactive for an isotype if their
titre was above the cut-off point of mean +2 standard
deviations of the negative control sera. Based on this
cut-off point, the least prevalent schistosome-specific iso-
type was IgA being detected in 31% of the participants
and then IgE detected in 50% of the participants. IgG1
was detected in 58% of the participants, while IgG4 was
the most prevalent response, detected in 74% of the par-
ticipants. Levels of the isotypes were plotted by age
groups in Figure 1b.
Earlier studies have shown that higher ratios of
IgG1 ⁄ IgA and IgE ⁄ IgG4 are associated with lower infec-
tion levels (10,31). Therefore, to determine whether the
relationship between S. haematobium infection and anti-
body responses in this study was consistent with those
reported from other earlier studies, the ratios of IgG1 ⁄ IgA
and IgE ⁄ IgG4 were calculated and plotted against schisto-
some infection intensities. The ratio of IgE ⁄ IgG4 showed
a significant inverse relationship with schistosome infec-
tion intensity (r = )0.21, P = 0.002, df = 210), so that
people with high values for these ratios carried little or no
schistosome infection (Figure 1c). The IgA ⁄ IgG1 ratio did
not show a significant association with infection intensity
(r = 0.11, P = 0.10, df = 210). The subsequent western
blotting analyses were performed to determine whether
these different isotypes recognized the same individual
native antigens.
Antigens recognized by the different isotypes
The potential repertoire of schistosome antigens recog-
nized on two-dimensional blots of adult parasite extract
was first defined with a highly reactive positive post-treat-
ment serum pool made from a subgroup of this popula-
tion previously used to investigate the effects of
praziquantel treatment on schistosome-specific responses
(26), which was probed with a secondary antibody combi-
nation reactive to IgA ⁄ IgG ⁄ IgM. This serum pool reacted
with a total of 71 spots compared to negative nonendemic
sera that reacted with none of the protein spots. The 71
proteins were identified and characterized in our previous
study (26) which gives their predicted molecular weights,
isoelectric point (pI), Mascot output statistic and acces-
sion numbers from NCBI.
Compared to the IgA ⁄ IgG ⁄ IgM positive control, no sin-
gle isotype in the serum pool recognized all of the 71 anti-
genic spots. The differences in recognition of the antigenic
spots between the isotypes were both qualitative and
quantitative. IgG1 recognized the largest number of spots
(n = 45) followed by IgA and IgE which both recognized
39 spots, with IgG4 recognizing the fewest antigenic
spots (n = 35) as shown in Figure 2 and Table 1. The most
strongly recognized antigens by all subclasses were the two
isoforms of glyceraldehyde-3-phosphate, some isoforms of
heat shock protein (HSP) 70 as well as some proteins still
to be identified (spots 60 and 61). The antigenic spots 2
(protein yet to be indentified), 6 (triose-phosphate isomer-
ase) and 15 (yet to be identified) were strongly recognized
by IgG1 but were not detected by any of the other iso-
types. There were two isoforms of fructose-1-6-bis-phos-
phate aldolase, one reactive with IgA (antigenic spot 25 in
Figure 2a) and one reactive with IgG1 (antigenic spot 23
in Figure 2a). Some antigens were not recognized at all
byany of the 4 isotypes tested; these included the muscle
proteins myosin (heavy and light chain), tropomyosin
and paramyosin, HSP 60 and some isoforms of enolase
and immunophilin. Some antigenic spots such as those
between spots 22 and 52 in Figure 2 were strongly recog-
nized by the sera but were in such low abundance in the
Coomassie reference gel that they could not be isolated
and identified by mass spectrometry as reported in previ-
ous studies (26,32).
To quantify the relationships between protein spot recog-
nition by different isotypes, the intensity of recognition of
each antigenic spot by each isotype was categorized by
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interquartile range (to reduce the effects of differences
arising because of intra-isotype variation in detection
thresholds) as shown in Table 1. The recognition intensity
of the spots was positively correlated so that for most spots,
those intensely recognized by IgA were also intensity recog-
nized by IgG1 (Figure 3a). Thirty-six of the 39 antigenic
spots recognized by IgA were also recognized by IgG1
(Table 1). However, IgG1 recognized an additional nine
spots indicated in Figure 3a (numbered spots on the y axis).
These resolved to the antigens fatty acid–binding protein
(a) (c)
(b)
Figure 1 Description of the individual study participants partitioned by age group. (a) Infection intensity for each individual calculated as
a mean of eggs ⁄ 10 mL of urine from at least two urine samples collected on consecutive days. (b) Antibody levels measured as optical den-
sities for each individual (c) The relationship between the ratios of IgG1 ⁄ IgA and IgE ⁄ IgG4 calculated from the values in (1B) above and
schistosome infection intensity for each individual participant. These show a significant negative association between the ratio IgE ⁄ IgG4
and infection intensity and no significant association between the IgG1 ⁄ IgA ratio and infection intensity.
F. Mutapi et al. Parasite Immunology
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(Sm14), phosphoglycerate kinase, triose-phosphate isomer-
ase, an isoform of fructose 1-6-bis-phosphate aldolase, HSP
70, calreticulin, and two proteins yet to be identified (spots
2 and 15). Conversely, IgA recognized three antigenic spots
not recognized by IgG1 (numbered spots on the x-axis of
Figure 3a). These were an isoform of enolase, an isoform of
fructose 1-6-bis-phosphate aldolase, and a protein (spot 50)
yet to be identified. These were also not recognized by
IgG4 (Figure 3d) or IgE (Figure 3f).
Similar patterns of correlations between isotypes, but
with some antigens being exclusively or largely recognized
by only one isotype, were seen in all other pairwise com-
parisons (Figure 3). IgE recognized all 34 antigenic spots
recognized by IgG4 as shown in Table 1 and Figure 3b. In
addition, it also recognized an isoform of 28-kDa glutathi-
one-S-transferase, phosphoglycerate kinase, actin 1, calreti-
culin and one protein (spot 16) still to be identified.
Of all recognized antigens, only triose-phosphate
isomerase (spot 6 in Figure 2 and Table 1), isoforms of
fructose 1-6-bis-phosphate aldolase (spots 23 and 25), eno-
lase (spot 26), HSP70 (spot 29) and spots 2 and 15 which
are proteins still to be identified were recognized by a sin-
gle isotype. The isoforms of fructose-1-6-bis-phosphate
aldolase were reactive with either IgA (antigenic spot 25
in Figure 2a) or IgG1 (antigenic spot 23 in Figure 2a) but
not with both. IgG1 recognized all of the antigenic spots
recognized by IgG4 (Table 1, Figure 3c) and IgE (Table 1,
Figure 3e).
Of the current World Health Organisation’s 10 schisto-
some vaccine candidates, only three were recognized by all
of the isotypes assayed. These were an isoform of 28-kDa
glutathione-S-transferase (spot 8), both isoforms of glyce-
ladeyde-3-phosphate (spots 21 and 22) and several iso-
forms of actin-binding ⁄ filamin-like protein (spots 66–69).
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Figure 2 Antigen recognition patterns of the serum pool compared by two-dimensional western blotting. (a) IgA vs. IgG1. (b) IgE vs.
IgG4.
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Table 1 The table gives identities of the antigenic spots in Figure 3, relating the spot number to its protein identity from the peptide
searches and recognition intensity by each of the isotypes
F. Mutapi et al. Parasite Immunology
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The vaccine candidate paramyosin was not recognized by
any of the antibodies assayed.
DISCUSSION
Passive transfer studies in animal models show that anti-
bodies can protect against schistosomiasis (5–8,33). In par-
allel, human immuno-epidemiology studies have shown
that some antibody classes are associated with low levels
of infection in endemic populations as well as low re-infec-
tion rates following treatment with antihelminthic drugs
(10,12,13,34–36). However, all previous studies to date
have focused on describing antibody responses either to
individual recombinant antigens or to uncharacterized
‘whole worm’ antigen preparations. We have previously
defined native schistosome adult proteins recognized by
the total IgG fraction of human serum from samples col-
lected from this same population (26). In this study, we
compare the reactivity of different isotypes to the soluble
component of adult worm crude antigen, separated into
its constituent defined antigens, to answer two questions.
First, which antigens are recognized by the different anti-
body iostypes IgA, IgE, IgG1 and IgG4? Second, do dif-
ferent isotypes recognize the same antigens? It is possible
that observed differences in recognition intensity reflect
not only the biological (functional) differences between the
isotypes but also differences in the sensitivity and specific-
ity of the isotypes, so that some antigens would be below
the detection limit of the assays. However, we have
carefully calibrated the dilutions of sera and secondary
antibodies to enable optimal comparison and minimize
this possibility. We have used three replicates of each blot
to verify the patterns and ratios of recognition intensity of
each protein spot that we observed for each of the four
isotypes. Thus, we have shown that some antigens from
within the adult S. haematobium proteome are preferen-
tially recognized by certain isotypes. For example, one
isoform of the antigen fructose-1-bis-phosphate aldolase
was intensely recognized by IgA but not detected by IgE,
IgG1 or IgG4. Furthermore, comparing recognition inten-
sity between isotypes using quartiles calculated within each
subclass (Table 1), rather than absolute values (Figure 3),
corrected for some intra-isotype variation in sensitivity.
The study was designed to extend our understanding of
the individual antigens detected in immunoassays routinely
conducted by ELISA using crude antigens. In these former
assays, protocols are designed to optimize sensitivity and
specificity as carried out here to reduce the effects of dif-
ferences in detection thresholds of the different isotypes.
The four isotypes we investigated detected a total of 48
antigenic spots of a possible 71 spots detected with total
IgG antibodies previously described by screening adult
worm antigens with post-treatment sera (26). The sera used
in this current study were from 7- to 18-year-olds before
Table 1 (Continued)
The WHO-listed schistosome vaccine candidates are highlighted in bold. The intensity of recognition is coded from no colour (antigenic spot
not detected), very light (1st quartile), (excluding the undetected spots in former category, i.e. recognition intensity >0), light (2nd quartile),
medium (3rd quartile) and darkest (4th quartile). The interquartile ranges were calculated separately for each isotype.
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enhancement of antibody reactivity with antihelminthic
treatment (26). Our previous study involved older people,
i.e. up to 42 years old, and included the reactivities of
the additional IgG subclasses IgG2, IgG3 which are reac-
tive against some of the schistosome vaccine candidates
(23). Therefore, it is not surprising that the number of
spots recognized by the IgG subclasses (IgG1 and IgG4)
in this study would be fewer than in previous studies.
Comparing the number of antigenic spots detected and
the prevalence of the response in the study population, it
is interesting that while IgG4 was the most prevalent
response in the study population (present in 74% of the
population), this isotype detected the least number of
antigenic spots, suggesting that there are few dominant
antigens stimulating the IgG4 response. Conversely, IgG1
detected in 58% of the participants, recognized the largest
number of spots, suggesting that the IgG1 response is
directed against a larger repertoire of antigens than the
other isotypes.
We have previously shown a dichotomous association
between IgA and IgG1 responses directed against adult
worm antigens in a different Zimbabwean population (13),
and the spot identification in Figure 3a shows that there
are some antigens recognized either by IgG1 or by IgA
but not by both antibodies. An inverse relationship has
also been reported in a case of idiopathic arthritis where
patients deficient in IgG1 had high titres of IgA (37), sug-
gesting that the expression of these two subclasses is dif-
ferentially regulated. IgG1 recognized the largest number
of antigenic spots: 45 including 8 of the 10 of the WHO’s
schistosome vaccine candidates. Furthermore, in this
study, IgG1 levels rose with age to peak in the oldest age
group with the least infection, suggesting that the antibody
is associated with protection against infection. This is
consistent with our previous studies showing an associa-
tion between antiworm IgG1 responses and protection to
S. haematobium infection (13). IgA recognized fewer anti-
genic spots than IgG1, reacting with only 3 of the 10
schistosome vaccine candidates including the leading vac-
cine candidate 28-kDa glutathione-S-transferase.
The ratio of IgE to IgG4 levels has previously been asso-
ciated with protection to re-infection by S. haematobium
infection (10), and the association of a high IgE ⁄ IgG4
ratio with little or no infection in our present study is con-
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Figure 3 Comparison of recognition intensity for each antigenic spot by the different isotypes showing a significant positive correlation
between all 4 isotypes. Italicized numbers refer to the spot identity of antigenic spots preferentially recognized by one of the two isotypes,
and their protein identities are given in Table 1. (a) IgG1 vs. IgA. (b) IgG4 vs. IgE. (c) IgG4 vs. IgG1. (d) IgG4 vs. IgA. (e) IgE vs. IgG1.
(f) IgE vs. IgA.
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sistent with these findings. The inverse relationship between
IgG4 and IgE has been used to suggest that IgG4 anti-
bodies might block IgE effector functions by competitively
binding to epitopes recognized by both isotypes and thereby
inhibit IgE-dependent cell cytotoxicity mediated by mono-
cytes, eosinophils or platelets (11,38). The IgG4 subclass is
upregulated in association with anti-inflammatory factors
[for example, IL-10 (39)] and its own anti-inflammatory
characteristics are thought to help the immune system to
dampen inappropriate inflammatory reactions (40). This
would only be possible if the two isotypes recognized the
same antigens. In this study, IgG4 bound to the fewest anti-
genic spots, while IgE recognized all those recognized by
IgG4. IgE reacted with seven of the 10 vaccine candidates,
five of which were also recognized by IgG4. The recognition
intensities (for each antigenic spot representing both affinity
and avidity) of these two antibodies were the most strongly
correlated in the study, suggesting a tightly regulated associ-
ation between them. Earlier studies in filariasis using wes-
tern blotting of one-dimensional gels indicated that the level
of cross-reactivity between IgE and IgG4 differed with the
level of pathology (41), which suggests that during the
course of infection, there is dissociation in antigen recogni-
tion patterns between the two antibodies. How this dissocia-
tion occurs is unclear but may be related to the order of
antibody class switching where IgG4-secreting B cells can
switch to IgE but not the converse (42) and ⁄or a threshold
being reached in antigen levels (32).
The antigens recognized by IgE but not IgG4, and by
IgG1 but not IgA, are of interest as they may be associated
with the development of resistance to schistosomiasis; this
is supported by the fact that most of these antigens are
already known vaccine candidates (23). Studies are now
underway to identify the proteins that were not serologi-
cally reactive, particularly those that are abundant in the
soluble proteome which might play an important role in
immune evasion and ⁄or modulation of the host immune
response (43). Similarly, there is a need to identify the
intensely recognized proteins that occurred at insufficient
concentrations in the adult worm proteome to be identified
by mass spectrometry, as these may indicate highly immu-
nogenic vaccine candidates as yet undiscovered.
Overall, our study has indicated that although the
majority of the antigens are recognized by all of the four
antibody isotypes tested, there may be restriction in anti-
gen recognition for some antigens, for example prevalent
isotypes such as IgG4 appear to react to relatively few of
the major adult worm antigens. This may partly explain
differences observed in population level isotype dynamics
in human schistosomiasis. Furthermore, there are differ-
ences in the recognition of isoforms of some antigens such
as the leading vaccine candidate, 28-kDa glutathione-
S-transferase and glyceraldehyde-3-phosphate dehydroge-
nase. These isoform-specific differences are an important
consideration for vaccine development, where recombinant
vaccines lack post-translational modifications and there-
fore epitopes crucial for induction of the relevant isotype-
specific antibody responses. Studies on antigen recognition
patterns by different antibodies present in sera from indi-
viduals or partitioning the study population by age and
infection status as we previously reported for total IgG
will be valuable for identifying further vaccine candidates
(32).
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SUPPORTING INFORMATION
Additional Supporting Information
may be found in the online version of
this article:
Figure S1. Enzyme-linked immuno-
sorbent titration assays to optimize
the sensitivity and specificity of the is-
otypes used in the assay using adult
worm antigen at 5 lg ⁄mL.
Figure S2. Western blot assays used
to optimize the sensitivity and speci-
ficity of the isotypes used.
Figure S3. Results of the western
blot assays using the negative control
sera (pooled from five European
donors who have never travelled to
tropical countries) diluted at 1 : 200
and IgG4 secondary antibody diluted
at 1 : 1000 showing no reactivity of
the negative control sera with schisto-
some adult women antigens.
Please note: Wiley-Blackwell are
not responsible for the content or
functionality of any supporting mate-
rials supplied by the authors. Any
queries (other than missing material)
should be directed to the correspond-
ing author for the article.
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